全文获取类型
收费全文 | 1229398篇 |
免费 | 96538篇 |
国内免费 | 23334篇 |
专业分类
耳鼻咽喉 | 15803篇 |
儿科学 | 27558篇 |
妇产科学 | 27888篇 |
基础医学 | 169928篇 |
口腔科学 | 33496篇 |
临床医学 | 122308篇 |
内科学 | 225961篇 |
皮肤病学 | 22091篇 |
神经病学 | 89002篇 |
特种医学 | 48279篇 |
外国民族医学 | 292篇 |
外科学 | 182727篇 |
综合类 | 66964篇 |
现状与发展 | 77篇 |
一般理论 | 252篇 |
预防医学 | 79536篇 |
眼科学 | 30512篇 |
药学 | 103652篇 |
326篇 | |
中国医学 | 19402篇 |
肿瘤学 | 83216篇 |
出版年
2022年 | 8024篇 |
2021年 | 18851篇 |
2020年 | 15461篇 |
2019年 | 16578篇 |
2018年 | 20124篇 |
2017年 | 16771篇 |
2016年 | 16893篇 |
2015年 | 22906篇 |
2014年 | 29408篇 |
2013年 | 32467篇 |
2012年 | 46282篇 |
2011年 | 50279篇 |
2010年 | 30361篇 |
2009年 | 26262篇 |
2008年 | 41143篇 |
2007年 | 42221篇 |
2006年 | 43081篇 |
2005年 | 41781篇 |
2004年 | 34896篇 |
2003年 | 33008篇 |
2002年 | 31268篇 |
2001年 | 61288篇 |
2000年 | 63856篇 |
1999年 | 55030篇 |
1998年 | 15419篇 |
1997年 | 14250篇 |
1996年 | 13285篇 |
1995年 | 12723篇 |
1994年 | 11393篇 |
1993年 | 9612篇 |
1992年 | 38013篇 |
1991年 | 36095篇 |
1990年 | 34644篇 |
1989年 | 33536篇 |
1988年 | 30398篇 |
1987年 | 29407篇 |
1986年 | 27250篇 |
1985年 | 25942篇 |
1984年 | 18286篇 |
1983年 | 15435篇 |
1982年 | 7975篇 |
1979年 | 15950篇 |
1978年 | 10646篇 |
1977年 | 9096篇 |
1975年 | 8665篇 |
1974年 | 10531篇 |
1973年 | 9920篇 |
1972年 | 9412篇 |
1971年 | 8886篇 |
1970年 | 8462篇 |
排序方式: 共有10000条查询结果,搜索用时 77 毫秒
81.
Die Anaesthesiologie - Eine junge Patientin erleidet während der Anlage einer axillären Plexusblockade einen generalisierten Krampfanfall. Die Mechanismen, im Wesentlichen die vermutlich... 相似文献
82.
83.
84.
Tianshu Liu Yuxian Bai Xiaoyan Lin Wei Li Jufeng Wang Xiaochun Zhang Hongming Pan Chunmei Bai Li Bai Ying Cheng Jingdong Zhang Haijun Zhong Yi Ba Wenwei Hu Ruihua Xu Weijian Guo Shukui Qin Nong Yang Jianwei Lu Kohei Shitara Ming Lei Mingshun Li Nicole Bao Tian Chen Lin Shen 《International journal of cancer. Journal international du cancer》2023,152(4):749-760
First-line chemotherapy for advanced/metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric/gastroesophageal junction cancer (GC/GEJC) has poor median overall survival (OS; <1 year). We report efficacy and safety results from Chinese patients in the phase III global CheckMate 649 study of nivolumab plus chemotherapy vs chemotherapy for the first-line treatment of GC/GEJC/esophageal adenocarcinoma (EAC). Chinese patients with previously untreated advanced or metastatic GC/GEJC/EAC were randomized to receive nivolumab (360 mg Q3W or 240 mg Q2W) plus chemotherapy (XELOX [capecitabine and oxaliplatin] Q3W or FOLFOX [oxaliplatin, leucovorin and 5-fluorouracil] Q2W), nivolumab plus ipilimumab (not reported) or chemotherapy alone. OS, blinded independent central review-assessed progression-free survival (PFS), objective response rate (ORR), duration of response (DOR) and safety are reported. Of 1581 patients enrolled and randomized, 208 were Chinese. In these patients, nivolumab plus chemotherapy resulted in clinically meaningful improvement in median OS (14.3 vs 10.2 months; HR 0.61 [95% CI: 0.44-0.85]), median PFS (8.3 vs 5.6 months; HR 0.57 [95% CI: 0.40-0.80]), ORR (66% vs 45%) and median DOR (12.2 vs 5.6 months) vs chemotherapy, respectively. The safety profile was acceptable, with no new safety signals observed. Consistent with results from the global primary analysis of CheckMate 649, nivolumab plus chemotherapy demonstrated a clinically meaningful improvement in OS and PFS and higher response rate vs chemotherapy and an acceptable safety profile in Chinese patients. Nivolumab plus chemotherapy represents a new standard first-line treatment for Chinese patients with non-HER2-positive advanced GC/GEJC/EAC. 相似文献
85.
86.
目的: 建立首批1,6-脱水衍生物系统适用性对照品,完善国家标准。方法:以欧洲药典依诺肝素钠对照品(EP Enoxaparin Sodium,Batch5)为系统适用性对照品,采用依诺肝素钠新国家标准草案 “1,6-脱水衍生物”检查法,对依诺肝素钠国家对照品(批号:140810-201801)进行1,6-脱水衍生物含量测定,由全国14个药品检验机构及依诺肝素生产企业实验室协作标定。结果:对依诺肝素钠系统适用性国家对照品(批号:140810-201801)1,6-脱水衍生物含量标定结果为20.3%,并对实验室内误差进行考察,14个实验室中有1个实验室(Lab1)标准差(SD)为1.8%,5个实验室(Lab2、Lab4、Lab10、 Lab11和Lab13)的SD为0.5%~0.7%,其余8个实验室的SD值均小于0.5%。对实验室间误差进行考察,有效数据的SD值为0.6%,相对标准偏差(RSD)为3.2%。结论:经国家药品标准物质委员会审定后批准, 依诺肝素系统适用性国家对照品(批号:140810-201801)增加1,6-脱水衍生物含量赋值,可以用于依诺肝素钠1,6-脱水衍生物检查系统适用性考察使用。 相似文献
87.
Manyu Gu Shuyi Wang Wandi Cao Dejian Yan Yi Cao 《Journal of applied toxicology : JAT》2022,42(4):651-659
Recently, we reported that titanium dioxide (TiO2) materials activated endothelial cells via Kruppel-like factor (KLF)-mediated nitric oxide (NO) dysfunction, but the roles of physical properties of materials are not clear. In this study, we prepared nanobelts from P25 particles and compared their adverse effects to human umbilical vein endothelial cells (HUVECs). TiO2 nanobelts had belt-like morphology but comparable surface areas as P25 particles. When applied to HUVECs, P25 particles or nanobelts did not induce cytotoxicity, although nanobelts were much more effective to increase intracellular Ti element concentrations compared the same amounts of P25 particles. Only nanobelts significantly induced THP-1 adhesion onto HUVECs. Consistently, nanobelts were more significant to induce the expression of intracellular adhesion molecule-1 (ICAM1) and the release of soluble ICAM-1 (sICAM-1), indicating that nanobelts were more potent to induce endothelial activation in vitro. As the mechanisms for endothelial activation, both P25 and nanobelts reduced the generation of intracellular NO as well as the expression of NO regulators KLF2 and KLF4. Combined, the results from this study indicated that the different morphologies of P25 particles and nanobelts only changed their internalization into HUVECs but showed minimal impact on KLF-mediated NO signaling pathways. 相似文献
88.
Melanie Y. T. Chan Arbab Anwar William J. S. Lockley 《Journal of labelled compounds & radiopharmaceuticals》2022,65(4):101-111
Base catalysed exchange with sodium hydroxide, calcium oxide or N,N,N,N-tetramethylguanidine in deuterium oxide is a viable procedure for the preparation of terminally deuterated alkynes for those alkynes stable to strong base. The use of silver perchlorate as a catalyst is an alternative practical option when labelling alkynes which are sensitive to base or contain functionalities which would lead to labelling elsewhere in the molecule. Labelling with this catalyst takes place smoothly at ambient temperature in a mixture of N,N-dimethylformamide and deuterium oxide. 相似文献
89.
90.